Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome: a Multicentre Double-blind Randomised Controlled Trial

NCT05524259 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05524259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome: a Multicentre Double-blind Randomised Controlled Trial
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
June 21, 2019
Completion date
February 29, 2024
Enrollment
464 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus, polycystic ovary syndrome, preeclampsia, preterm birth